Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PANDORA SP.ADR 1/4 DK 1 | 3P70 | Nov 22, 2024 | 36.20 | +1.69 |
Pandox B | POX | Nov 22, 2024 | 15.24 | -0.26 |
Pangea Natural Foods Inc | XU0 | Nov 22, 2024 | 0.01 | +5.00 |
Pangenomic Health | LL31 | Nov 22, 2024 | 0.16 | 0.00 |
Pangenomic Health | LL3 | 0.00 | 0.00 | |
Panin Financial Tbk | OHH | Nov 22, 2024 | 0.02 | -2.22 |
PannErgy Plc. | PPL | Nov 22, 2024 | 3.56 | -0.28 |
Panoply Holdings Plc | 9L7 | Nov 22, 2024 | 0.37 | -1.60 |
Panoro Energy | 1PZ | Nov 22, 2024 | 2.19 | -0.90 |
Panoro Minerals Ltd. | PZM | Nov 22, 2024 | 0.25 | -0.79 |
Pantaflix AG | PAL | Nov 22, 2024 | 1.20 | 0.00 |
Pantheon International Plc | PAA0 | Nov 22, 2024 | 3.78 | 0.00 |
Pantheon Resources | P3K | Nov 22, 2024 | 0.29 | -2.88 |
Pantoro Limited | RKN | Nov 22, 2024 | 0.06 | +0.86 |
Papa Johns International, Inc. | PP1 | Nov 22, 2024 | 45.60 | +3.17 |
PAPOUTSANIS SA NA.EO -,54 | Y2O | Nov 22, 2024 | 2.27 | -0.87 |
Par Pacific Holdings, Inc. | 61P | Nov 22, 2024 | 16.50 | +1.23 |
PAR Technology Corporation | 35U | Nov 22, 2024 | 73.50 | +2.80 |
PARADIGM BIOPHARMACEUT. | P86 | Nov 22, 2024 | 0.20 | +21.12 |
PARADISE ENT | LIL3 | Nov 22, 2024 | 0.11 | -6.78 |
Paradox Interactive | ETA | Nov 22, 2024 | 15.59 | -0.57 |
Paragon 28 Inc | 7GQ | Nov 22, 2024 | 9.85 | +2.07 |
Paragon Banking Group Plc | 46P1 | Nov 22, 2024 | 8.85 | +1.14 |
Paragon Care Limited | PXS | Nov 22, 2024 | 0.30 | +1.37 |
Paragon GmbH & Co. KGaA | PGN | Nov 22, 2024 | 1.83 | +1.67 |
Paramount Gold Nevada Corp. | P9G | Nov 22, 2024 | 0.35 | +2.33 |
Paramount Group, Inc. | 6PM | Nov 22, 2024 | 4.45 | +0.98 |
Paramount Resources Ltd. | PQ51 | Nov 22, 2024 | 20.80 | +0.97 |
PARATUS ENER.SVS DL 4,9 | U6N | Nov 22, 2024 | 4.11 | +1.83 |
Paref | G5I | Nov 22, 2024 | 39.70 | +0.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.